Overview of the genomic mutation spectrum
tumor
TUMOR
In the prespecified exploratory analysis, we first evaluated the association between genomic alteration and clinical response to sintilimab combined with GemCis in all the enrolled participants with pretreatment tumor biopsies for targeted 539 cancer-relevant genes sequencing. Fig 